Title
Phase 1 Trial of Vamorolone, a First-in-Class Steroid, Shows Improvements in Side Effects via Biomarkers Bridged to Clinical Outcomes.
Document Type
Journal Article
Publication Date
6-1-2018
Journal
Steroids
Volume
134
Inclusive Pages
43-52
DOI
10.1016/j.steroids.2018.02.010
Keywords
Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pregnadienediols; Quality of Life; Safety; Treatment Outcome; Young Adult
APA Citation
Hoffman, E., Riddle, V., Siegler, M., Dickerson, D., Backonja, M., Kramer, W., Nagaraju, K., Gordish-Dressman, H., Damsker, J., & McCall, J. (2018). Phase 1 Trial of Vamorolone, a First-in-Class Steroid, Shows Improvements in Side Effects via Biomarkers Bridged to Clinical Outcomes.. Steroids, 134 (). http://dx.doi.org/10.1016/j.steroids.2018.02.010
Peer Reviewed
1